CD8+ TCR repertoire formation is guided primarily by the peptide component of the antigenic complex

Koning, D., Costa, A. I., Hoof, I., Miles, John James, Nanlohy, N. M., Ladell, Kristin Ingrid ORCID: https://orcid.org/0000-0002-9856-2938, Matthews, Katherine K., Venturi, V., Schellens, I. M. M., Borghans, J. A. M., Kesmir, C., Price, David ORCID: https://orcid.org/0000-0001-9416-2737 and van Baarle, D. 2013. CD8+ TCR repertoire formation is guided primarily by the peptide component of the antigenic complex. The Journal of Immunology 190 (3) , pp. 931-939. 10.4049/jimmunol.1202466

Full text not available from this repository.

Abstract

CD8+ T cells recognize infected or dysregulated cells via the clonotypically expressed αβ TCR, which engages Ag in the form of peptide bound to MHC class I (MHC I) on the target cell surface. Previous studies have indicated that a diverse Ag-specific TCR repertoire can be beneficial to the host, yet the determinants of clonotypic diversity are poorly defined. To better understand the factors that govern TCR repertoire formation, we conducted a comprehensive clonotypic analysis of CD8+ T cell populations directed against epitopes derived from EBV and CMV. Neither pathogen source nor the restricting MHC I molecule were linked with TCR diversity; indeed, both HLA-A and HLA-B molecules were observed to interact with an overlapping repertoire of expressed TRBV genes. Peptide specificity, however, markedly impacted TCR diversity. In addition, distinct peptides sharing HLA restriction and viral origin mobilized TCR repertoires with distinct patterns of TRBV gene usage. Notably, no relationship was observed between immunodominance and TCR diversity. These findings provide new insights into the forces that shape the Ag-specific TCR repertoire in vivo and highlight a determinative role for the peptide component of the peptide–MHC I complex on the molecular frontline of CD8+ T cell–mediated immune surveillance.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine Systems Immunity Research Institute (SIURI)
Subjects:	Q Science > QR Microbiology > QR180 Immunology R Medicine > RM Therapeutics. Pharmacology
Publisher:	American Association of Immunologists
ISSN:	0022-1767
Last Modified:	10 Jun 2023 01:09
URI:	https://orca.cardiff.ac.uk/id/eprint/61491

Citation Data

Cited 27 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item